Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer

Clinical trial NCT03180528 · COMPLETED

Trial details

NCT number: NCT03180528
Sponsor: Kavita Sarin
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Skin Basal Cell Carcinoma

Start date: 2018-07-07
Primary completion: 2020-07-07
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.